Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Net Cash Flow (2022 - 2026)

Phathom Pharmaceuticals (PHAT) has disclosed Net Cash Flow for 5 consecutive years, with $50.9 million as the latest value for Q1 2026.

  • For Q1 2026, Net Cash Flow rose 159.96% year-over-year to $50.9 million; the TTM value through Mar 2026 reached -$31.4 million, up 71.42%, while the annual FY2025 figure was -$167.3 million, 98.85% down from the prior year.
  • Net Cash Flow hit $50.9 million in Q1 2026 for Phathom Pharmaceuticals, up from -$5.2 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $167.7 million in Q4 2023 and bottomed at -$84.9 million in Q1 2025.
  • Average Net Cash Flow over 5 years is -$5.6 million, with a median of -$26.1 million recorded in 2022.
  • On a YoY basis, Net Cash Flow climbed as much as 556.3% in 2023 and fell as far as 211.16% in 2023.
  • Phathom Pharmaceuticals' Net Cash Flow stood at -$41.5 million in 2022, then skyrocketed by 504.61% to $167.7 million in 2023, then tumbled by 122.31% to -$37.4 million in 2024, then soared by 86.14% to -$5.2 million in 2025, then surged by 1082.3% to $50.9 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at $50.9 million, -$5.2 million, and -$14.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.